Abstract
We examined the IL-6 gene promoter and detected several interesting promoter polymorphisms: GGGCTG insertion at +162 bp and G deletion at +168 bp positions (M1), A to G substitution at −594 bp (M2) of the reported IL-6 promoter sequence. Other rare variations were also observed at several positions: −583 bp (T insertion), −507 bp (C insertion), −71 bp (T deletion), +17 bp (C insertion), and +121 bp (GC insertion). Although Kawasaki disease (KD) patients demonstrate a drastic increase in serum interleukin-6 (IL-6) during the acute phase that parallels the duration of fever, there were no significant differences in the nucleotide sequence between the KD patients and normal control group. By transient transfection with IL-6 gene promoter-luciferase fusion plasmids into CV-1 cells, we tested the functional significances of the polymorphisms. Mutations at +162 bp, +168 bp and −594 bp significantly decreased luciferase expression (P < 0.05), suggesting the promoter elements flanking the mutated nucleotides are important in transcriptional activation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 digital issues and online access to articles
$119.00 per year
only $19.83 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kawasaki T Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children: Clinical observations of 50 cases Jpn J Allerg 1967 16 178–222
Kawasaki T, Kosaki F, Osawa S, Shigematsu I, Yanagawa S A new infantile acute febrile mucocutaneous lymphnode syndrome (MCLS) prevailing in Japan Pediatrics 1974 54 271–276
Leung DYM, Chu ET, Wood N, Grady S, Meade R, Gdha R Immunoregulatory T cell abnormalities in MCLS J Immunol 1983 130 2002–2004
Furukawa S, Matsubara T, Jujho K et al Peripheral blood monocyte macrophage and serum tumor necrosis factor in Kawasaki disease Clin Immunol Immunopathol 1988 48 247–251
Furukawa S, Matsubara T, Motohashi T, Nakachi S, Sasai K, Yabuta K Expression of FcεR2/CD23 on peripheral blood macrophages/monocytes in Kawasaki disease Clin Immunol Immunopathol 1990 56 280–286
Laxer RL, Schffer FL, Myones B et al Lymphocyte abnormalities and complement activation in Kawasaki disease Prog Clin Biol Res 1987 250 175–184
Kim DS, Han BH, Lee SK, Lee HK, Chaw YJ, Lee KY Evidence for selection of 11 amino acid CDR3 domains in VκIII-derived immunoglobulin light chains in Kawasaki disease Scand J Rheumatol 1997 26 350–354
Kim DS, Hwang HY, Yu CJ Oligoclonal expansion of the VH family in Kawasaki disease J Korean Pediatr Soc 1999 42 1246–1254
Lang BA, Silveramn ED, Laxer RM, Lau AS Spontaneous tumor necrosis factor production in Kawasaki disease J Pediatr 1989 115 939–943
Maury CPJ, Salo E, Pelkonen D Circulating interleukin-1β in patients with Kawasaki disease N Engl J Med 1988 319 1670–1671
Kim DS Serum interleukin-6 in Kawasaki disease Yonsei Med J 1992 33 183–188
Ueno Y, Takano N, Kanegane H et al The acute phase nature of interleukin-6: studies in Kawasaki disease and other febrile illness Clin Exp Immunol 1989 76 337–342
Hirano T, Akira S, Taga T, Kishimoto T Biological and clinical aspects of interleukin-6 Immunol Today 1990 11 443–449
Kim MK, Kim DS The interleukin-6 level in Kawasaki disease J Korean Pediatr Soc 1992 35 515–525
Olomolaiye OO, Wood NAP, Bidwell JL A novel NlaIII polymorphism in the human IL-6 promoter Eur J Immunogen 1998 25 267–268
Faulds G, Fishman D, Woo P, Humphries S Novel FokI polymorphism in the 5′ flanking region of the human IL-6 gene. Genbank/EMBL, Accession number AF048692
Nakajima T, Ota N, Yoshida H, Watanabe S, Suzuki T, Emi M Allelic variants in the interleukin-6 gene and essential hypertension in Japanese women Genes Immun 1999 1 115–119
Osiri M, McNicholl J, Moreland LW, Bridges SL Jr A novel single nucleotide polymorphism and five probable haplotypes in the 5′ flanking region of the IL-6 gene in African-Americans Genes Immun 1999 1 166–167
Jordanides N, Eskdale J, Stuart R, Gallagher G Allele associations reveal four prominent haplotypes at the human interleukin-6 (IL-6) locus Genes Immun 2000 1 451–455
Linker-Israeli M, Wallace DJ, Prehn JL, Nand R, Li L, Klinenberg JR A great variability in the 3′ flanking region of the IL-6 gene in patients with systemic lupus erythematosus (SLE) Autoimmunity 1996 23 199–209
Papassotiropoulos A, Bagli M, Jessen F et al A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer’s disease Ann Neurol 1999 45 666–668
Fishman D, Faulds G, Jeffery R et al The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis J Clin Invest 1998 102 1369–1376
Collado-Escobar MD, Nieto A, Mataran L, Raya E, Martin J Interleukin 6 gene polymorphism in not associated with ankylosing spondylitis J Rheumatol 2000 27 1461–1463
Mason WH, Takahashi M Kawasaki syndrome Clin Infect Dis 1999 28 169–187
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was partially supported by the Pediatric Fund of YUMC (JS Kim, HK Lee).
Rights and permissions
About this article
Cite this article
Sohn, M., Hur, MW. & Kim, D. Interleukin 6 gene promoter polymorphism is not associated with Kawasaki disease. Genes Immun 2, 357–362 (2001). https://doi.org/10.1038/sj.gene.6363785
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gene.6363785
Keywords
This article is cited by
-
Susceptibility genes for Kawasaki disease: toward implementation of personalized medicine
Journal of Human Genetics (2009)